Literature DB >> 28127338

Prevalence of Intestinal Coccidial Infections among Different Groups of Immunocompromised Patients.

Ghodratollah Salehi Sangani1, Hamed Mirjalali2, Shohreh Farnia1, Mostafa Rezaeian1.   

Abstract

BACKGROUND: Cryptosporidium and Isospora are known as one of the main cause of diarrhea in both immunocompetent and immunocompromised subjects, all over the world. Incidence of enteropathogens such as Cryptosporidium spp. and Isospora belli considerably has increased, since immunodeficiency virus (HIV) rapidly disseminated. In addition, cancer patients are highly susceptible to opportunistic infections. This study aimed to estimate the prevalence of cryptosporidiosis and isosporiasis in immunocompromised patients in Tehran.
METHODS: This study carried out on patients admitted to Imam Khomeini hospital during 2013-2014. Stool samples collected from 350 immunocompromised patients. Formol-ether concentration was performed for all stool samples. Zeil-Neelsen technique was applied to stain the prepared smears and finally, all slides were examined by light microscope.
RESULTS: Out of 350 patients, 195 (55.7%) and 155 (44.3%) were male and female, respectively. Cryptosporidium oocysts were detected in 3 (0.9%) samples including one sample from HIV+/AIDS patients and 2 samples from organ transplant recipients. Isospora oocysts were detected in 4 (1.1%) samples consisting 2 HIV+/AIDS patients, one patients suffering from malignancy and one patients with other immunodeficiency diseases.
CONCLUSION: Cryptosporidium sp, and I. belli are the most prevalent gastrointestinal parasitic protozoans that infect a broad range of individuals, particularly those patients who have a suppressed or deficient immunity system.

Entities:  

Keywords:  Cryptosporidiosis; Immunocompromised; Iran; Isosporiasis

Year:  2016        PMID: 28127338      PMCID: PMC5256049     

Source DB:  PubMed          Journal:  Iran J Parasitol        ISSN: 1735-7020            Impact factor:   1.012


Introduction

Coccidian genuses are microscopic protozoan parasites that infect the intestinal tract of the majority of human and animal subjects. These organisms are one of the major concerns for physicians, especially with increasing the rate of immunodeficiency disorders. The coccidian parasites (Cryptosporidium spp., Isospora belli, and Cyclospora spp.) are the most common enteric parasites in immunocompromised patients that can usually lead to lethal severe diarrhea while are considered as causative agents of a mild and self-limiting gastrointestinal disorders in immunocompetent individuals (1). Cryptosporidium and Isospora are recognized as significant and widespread causes of diarrheic disease in both immunocompetent and immunosuppressed individuals that has also been described as traveler disease (2, 3). Incidence of gastrointestinal parasites, especially Cryptosporidium sp. and I. belli considerably has increased, since immunodeficiency disorders rapidly disseminated. These two parasites display many similarities in their clinical symptoms (4). Diarrhea is one of the major complications, approximately occurring in 90% of HIV/AIDS patients and with low prevalence in other acquired and/or congenital immunodeficiency conditions, particularly in developing countries (5). Cancer patients and transplantation recipients who take immunosuppressive therapy and also patients with metabolic disorders are highly susceptible to opportunistic infections (6). Acute or chronic diarrheic syndromes resulting from these parasites are usually accompanied by weight loss, dehydration, abdominal pain, and mal-absorption syndrome in immunocompromised patients (4). Chronic diarrhea can lead to the increase in morbidity and mortality in these patients (4). Diarrhea with fluid loss of 25 L/day has been seen in infected patients, which can persist for weeks in immunocompromised patients (6). Cryptosporidium infects the microvillus border of the gastrointestinal epithelium of many vertebrate hosts (7). There are 5 known species of Cryptosporidium (C. hominis, C. parvum, C. meleagridis, C. felis, and C. canis), capable to induce human cryptosporidiosis that C. parvum and C. hominis are considered as more common species (8). I. belli is one of the opportunistic coccidian parasites that affects HIV+/AIDS patients, especially in developing countries of Africa, Asia, and Latin America with low levels of hygiene. It is always considered as a neglected parasite and the presence of this parasite because of the lack of enough investigation, particularly in immunocompromised patients, is underestimated (9). Various risk factors like using contaminated drinking water, animal exposure etc., have been reported to be associated with the gastrointestinal infection (10). There are several studies in Iran mainly on Cryptosporidium spp (11–14). Most of the published studies on Isospora in Iran are focused on case reports (15–18). The prevalence rate of Cryptosporidium spp., infection has been studied in different groups of people such as immunocompromised patients as well as diarrheic children. It was even reported up to 11.5% in chronic hemodialysis patients (13). The aim of this study was to provide new insight into the prevalence of cryptosporidiosis and isosporiasis in immunocompromised patients in Iran.

Materials and Methods

This cross-sectional study was carried out at the laboratory of Intestinal Parasitic Protozoans, School of Public Health, Tehran University of Medical Sciences in Tehran. Stool samples were collected from patients suffering from acquired/congenital immunodeficiency and/or those patients who had undergone immunosuppressive medications, during 2013–2014. All patients had been admitted to Imam Khomeini Hospital in one of the three following sections including Infectious, Oncology and Transplantation Departments. All stool samples of the patients were immediately transferred to the laboratory of Intestinal Parasitic Protozoans in Department of Medical Parasitology and Mycology, Tehran University of Medical Science for further investigations. Totally, 350 stool samples were collected from four groups of immunocompromised patients consisting 80 (23%) HIV/AIDS individuals with CD4+ lymphocyte count of less than 200 cells/μL and a history of Anti-Retroviral Therapy (ART), 15 (4%) organ transplant recipients, 234 (67%) patients suffering from malignancy undergoing chemotherapy and 21 (6%) patients with other congenital/acquired immunodeficiency disorders. Conventional formalin-ether concentration was performed for all stool samples. Slim slides were prepared for each sample and then all slides were dried in room temperature and were fixed with absolute methanol for 1 min. Finally, all samples were stained using conventional Zeil-Neelsen method. Microscopic examination was performed for each slide with at least 200–300 fields using 100× oil immersion objective. All slides were examined by an observer and positive slides confirmed by second observer. Stool specimens containing un-sporulated oocysts were kept in potassium dichromate 2% at room temperature to develop two mature sporocysts after 4–5 d (Fig. 1, 2c).
Fig. 1:

Oocysts of Cryptosporidium isolated from stool in Zeil-NeelsenStain

Fig. 2:

Oocysts of Isospora isolated from stool in Ziehl-Nielsen Stain; variation in staining of sporoblast ; Red-stained oocyst (A); Unstained ghost (B); Sporulated oocyst in direct wet smear (C)

Oocysts of Cryptosporidium isolated from stool in Zeil-NeelsenStain Oocysts of Isospora isolated from stool in Ziehl-Nielsen Stain; variation in staining of sporoblast ; Red-stained oocyst (A); Unstained ghost (B); Sporulated oocyst in direct wet smear (C)

Results

Out of 350 patients, 195(55.7%) were male and 155(44.3%) were female. The mean+ SD of age of patients was 45.5 + 15.41 yr. Cryptosporidium sp, and I. belli were the only coccidian detected. Coccidian oocysts were identified in 7 (2%) of the stool samples. Cryptosporidium oocysts were detected in 3 (0.9%) samples including one HIV/AIDS patients and 2 organ transplant recipients (Table 1). Isospora oocysts were detected in 4 (1.1%) samples consist of 2 HIV/AIDS patients, one patients suffering from malignancy and one patients with other congenital/acquired immunodeficiency disorders.
Table 1:

Prevalence of coccidian parasites identified in different groups of patients

Number of patientsCryptosporidium Number (%)Isospora Number (%)
AIDS patients801 (1.2)2 (2.5)
Organtransplant recipients152 (13.3)0
Malignancy2340 (0)1 (0.4)
Other congenital/acquired immunodeficiency disorders210 (0)1 (4.7)
Total3503 (0.9)4 (1.1)
Prevalence of coccidian parasites identified in different groups of patients

Discussion

Cryptosporidium, Isospora and Cyclospora are increasingly becoming prevalent in immunocompromised patients. Humans can acquire cryptosporidial infections through the fecal-oral route via direct person-to-person or animal-to-person contact as well as consumption of contaminated water or food (19) while no animal reservoir was identified for human isosporiasis (20). Although, animals are known as potential source of cryptosporidiosis, but environmental water resources are also described as one of the main sources of Cryptosporidium (21). Cryptosporidium spp., could be found in surface and groundwater resources via fecal contamination, that can infect drinking water resources (22). Interestingly, Cryptosporidium oocysts are able to pass through water treatment process because of their small size and resistance to routine disinfectants (8). Cryptosporidium transmission also occurs in care centers of children that share toilets and common play areas, or through diaper changing (6). However, the rate of infection is different from 0.6 – 85% for Cryptosporidium and 0.2–20% for I. belli depending on the study population and detection techniques (4). Cryptosporidium oocysts were recorded from 6.1 and 2.1% of general population of developing and developed countries, respectively (21). However, the prevalence rates of cryptosporidiosis among HIV+/AIDS diarrheic patients were significantly higher than 10% (21). Another study that reported a prevalence rate of cryptosporidiosis in 7% of diarrheic children represented a significant positive correlation between the infection and under-weight children. (11). Results of the study on diarrheic AIDS or AML patients in health centers of Tehran showed that the prevalence of cryptosporidiosis was 33.4% and 11.1%, respectively (12). Prevalence of cryptosporidiosis in hemodialysis patients was higher than control groups in Iran (13). HIV status was associated with infection of Cryptosporidium, I. belli, and Strongyloides stercoralis. However, HIV likely had no significant effects on increasing reports of the prevalence of other protozoan or helminthic infections (23). The common human-coccidian parasites were significantly seen in HIV/AIDS patients compared with healthy control subjects (1, 14, 23, 24). In the current study, a high prevalence of Cryptosporidium and Isospora in HIV/AIDS patients together with reduced CD4 lymphocyte count confirms susceptibility of HIV/AIDS patients to opportunistic infections. Although, isosporiasis has worldwide distribution especially in tropical and subtropical regions, but there are rare reports of this infection (25). I. belli is considered as an opportunistic infection in immunocompromised individuals, mainly AIDS patients, all over the world. Isosporiasis has been reported as the most prevalent intestinal parasitic disease among AIDS patients (26, 27). Assis and colleagues reported the frequency rate 10.1% and 6.7% in HIV-positive patients for Cryptosporidium sp., and I. belli, respectively (28). In another study, the prevalence rate of isosporiasis in Nigeria was reported 3.1% in HIV-positive patients while no Isospora infection was observed in the healthy control (25). Our results showed that the frequency rate of isosporiasis in HIV/AIDS patients was 2.5%. Therefore, our finding is in agreement with other studies that have suggested low prevalence rate of isosporiasis in immunocompromised patients, particularly HIV/AIDS patients. However, although treatment of isosporiasis usually is successful but recurrence cases are common (26). Detection of Isospora in direct examination of stool samples in most of laboratories is unusual. On the other hand, cases of isosporiasis has being raised up together with increase of HIV-infected subjects that can increase gastrointestinal complications in immunocompromised patients. Few studies have conducted on isosporiasis in Iran (14, 29). The first human isosporiasis was reported in 1961 and the second one was recorded from a 9-yr-old girl in Mashhad (16). Afterwards, 10 cases of human infection with I. belli were presented in 1991 in Iran (17). Another study reported isosporiasis from a patient who had been hospitalized due to car accident in 2001 (15). The first report of co-infection of Cryptosporidium and Isospora in Iran was carried out from an AIDS patient suffering from diarrhea in 2006 (7). A study showed Isospora infection from a 3-yr-old girl with HIV infection (18). Isosporiasis is usually transmitted through ingestion of sporulated oocysts from contaminated food and water (20). Although, some of cases of isosporiasis have been reported from homosexual patients (30), but because of the fact that isospora oocysts require to mature and become infectious in the environment, direct fecal-oral contact is unlikely to be the rout of usual transmission (31). Therefore, sanitation of water and food is very important in prevention programs. However, as mentioned, although isosporiasis reports are low, but this infection should be considered as a neglected disease in Iran, particularly in those subjects that have immunity disorders.

Conclusion

Cryptosporidium spp., and I. belli are the most prevalent gastrointestinal parasitic protozoans that infect a broad range of patients who have a suppressed or deficient immune system.
  24 in total

1.  Cryptosporidium infection in diarrheic children in southeastern Iran.

Authors:  Yaghoob Hamedi; Omid Safa; Mehregan Haidari
Journal:  Pediatr Infect Dis J       Date:  2005-01       Impact factor: 2.129

2.  Detection of cryptosporidium in immunosuppressed patients.

Authors:  R Baqai; S Anwar; S U Kazmi
Journal:  J Ayub Med Coll Abbottabad       Date:  2005 Jul-Sep

3.  High proportion of isosporiasis among HIV-infected patients with diarrhea in southern India.

Authors:  R Vignesh; P Balakrishnan; E M Shankar; K G Murugavel; S Hanas; A J Cecelia; S P Thyagarajan; Suniti Solomon; N Kumarasamy
Journal:  Am J Trop Med Hyg       Date:  2007-11       Impact factor: 2.345

4.  Chronic diarrhoea in HIV patients: prevalence of coccidian parasites.

Authors:  S Gupta; S Narang; V Nunavath; S Singh
Journal:  Indian J Med Microbiol       Date:  2008 Apr-Jun       Impact factor: 0.985

5.  Isospora belli enteritis in three homosexual men.

Authors:  D N Forthal; S S Guest
Journal:  Am J Trop Med Hyg       Date:  1984-11       Impact factor: 2.345

6.  Intestinal parasitic infection in HIV infected patients with diarrhoea in Chennai.

Authors:  S S Kumar; S Ananthan; P Lakshmi
Journal:  Indian J Med Microbiol       Date:  2002 Apr-Jun       Impact factor: 0.985

7.  Enteric opportunistic parasites among HIV infected individuals: associated risk factors and immune status.

Authors:  Kaushal Kumar Dwivedi; Ganga Prasad; Sanjeev Saini; Surbhi Mahajan; Shiv Lal; Usha Krishan Baveja
Journal:  Jpn J Infect Dis       Date:  2007-05       Impact factor: 1.362

8.  Isosporiasis in HIV/AIDS Patients in Edo State, Nigeria.

Authors:  Akinbo Frederick Olusegun; Christopher Ehis Okaka; Ricardo Luiz Dantas Machado
Journal:  Malays J Med Sci       Date:  2009-07

9.  Cryptosporidiosis in immunocompromised patients in the Islamic Republic of Iran.

Authors:  Hossein Nahrevanian; Mehdi Assmar
Journal:  J Microbiol Immunol Infect       Date:  2008-02       Impact factor: 4.399

10.  Intestinal parasitic infections in relation to HIV/AIDS status, diarrhea and CD4 T-cell count.

Authors:  Shimelis Assefa; Berhanu Erko; Girmay Medhin; Zelalem Assefa; Techalew Shimelis
Journal:  BMC Infect Dis       Date:  2009-09-18       Impact factor: 3.090

View more
  6 in total

1.  Blastocystis and Clostridioides difficile: Evidence for a Synergistic Role in Colonization Among IBD Patients with Emphasis on Ulcerative Colitis.

Authors:  Masoumeh Azimirad; Sara Mohammad Ali Gol; Ehsan Javanmard; Hamed Mirjalali; Abbas Yadegar; Hamid Asadzadeh Aghdaei; Shabnam Shahrokh; Hedieh Balaii; Amir Sadeghi; Mohammad Reza Zali
Journal:  Turk J Gastroenterol       Date:  2021-06       Impact factor: 1.852

2.  Changes in Systemic Regulatory T Cells, Effector T Cells, and Monocyte Populations Associated With Early-Life Stunting.

Authors:  Zo Andriamanantena; Fanirisoa Randrianarisaona; Maheninasy Rakotondrainipiana; Prisca Andriantsalama; Ravaka Randriamparany; Rindra Randremanana; Frédérique Randrianirina; Sophie Novault; Darragh Duffy; François Huetz; Milena Hasan; Matthieu Schoenhals; Philippe J Sansonetti; Pascale Vonaesch; Inès Vigan-Womas
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

Review 3.  Prevalence of Cryptosporidium, microsporidia and Isospora infection in HIV-infected people: a global systematic review and meta-analysis.

Authors:  Ze-Dong Wang; Quan Liu; Huan-Huan Liu; Shuang Li; Li Zhang; Yong-Kun Zhao; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2018-01-09       Impact factor: 3.876

4.  Prevalence of cryptosporidiosis and hygiene practices among HIV/AIDS patients in southwest Uganda.

Authors:  Juliet Nakibirango; Vincent Mugenyi; Dickson Nsaba; Aron Nsimemukama; Simon Peter Rugera; Benson Okongo
Journal:  HIV AIDS (Auckl)       Date:  2019-06-18

5.  Cryptosporidiosis in HIV-positive patients and related risk factors: A systematic review and meta-analysis.

Authors:  Ehsan Ahmadpour; Hanie Safarpour; Lihua Xiao; Mehdi Zarean; Kareem Hatam-Nahavandi; Aleksandra Barac; Stephane Picot; Mohammad Taghi Rahimi; Salvatore Rubino; Mahmoud Mahami-Oskouei; Adel Spotin; Sanam Nami; Hossein Bannazadeh Baghi
Journal:  Parasite       Date:  2020-04-30       Impact factor: 3.000

Review 6.  Opportunistic parasitic infections in patients with human immunodeficiency virus/acquired immunodeficiency syndrome: A review.

Authors:  D A Laksemi; L T Suwanti; M Mufasirin; K Suastika; M Sudarmaja
Journal:  Vet World       Date:  2020-04-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.